Extracted from this filing and checked against the source text.
Material AgreementsSEC 8-K Item 1.01/1.02confidence 0.9
Archer Aviation Inc. entered into Manufacturing Collaboration Agreement with Stellantis N.V. (effective 2023-01-03).
Action
entry
Agreement
collaboration
Counterparty
Stellantis N.V.
Effective
2023-01-03
Exact text from the filing
On January 3, 2023, Archer Aviation Inc. (the “Company”) entered into a Manufacturing Collaboration Agreement (the “Collaboration Agreement”) with Stellantis N.V. (“Stellantis”), pursuant to which the Company and Stellantis will collaborate on the development and implementation of the Company’s manufacturing operations for the production of its eVTOL aircraft products.
Material AgreementsSEC 8-K Item 1.01/1.02confidence 0.9
Archer Aviation Inc. entered into Warrant Agreement with Stellantis N.V. valued at up to 15.0 million (effective 2023-01-03).
Action
entry
Agreement
equity purchase
Counterparty
Stellantis N.V.
Value
up to 15.0 million
Effective
2023-01-03
Exact text from the filing
the Company and Stellantis entered into a warrant to purchase Class A Shares of the Company (the “Warrant Agreement”), dated January 3, 2023, pursuant to which Stellantis is entitled to purchase up to 15.0 million
Material AgreementsSEC 8-K Item 1.01/1.02confidence 0.9
Archer Aviation Inc. entered into Forward Purchase Agreement with Stellantis N.V. valued at $150.0 million (effective 2023-01-03).
Action
entry
Agreement
equity purchase
Counterparty
Stellantis N.V.
Value
$150.0 million
Effective
2023-01-03
Exact text from the filing
the Company entered into a forward purchase agreement (the “Forward Purchase Agreement”) with Stellantis on January 3, 2023, pursuant to which the Company may elect, in the Company’s sole discretion, to issue and sell to Stellantis up to $150.0 million of shares (“Forward Purchase Shares”) of the Company’s Class A Common Stock
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.